DRIVing Simulator and People With NeuroCognitive Disorders
NCT ID: NCT06320639
Last Updated: 2024-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2023-10-03
2026-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Despite their loss of autonomy and medical advice, 22% of people with major NCD continue to drive. In addition, the presence of minor NCD also puts people at a higher risk of road accidents.
However, several studies demonstrated that an NCD does not lead to a systematic and immediate impairment of driving ability and abruptly stopping driving leads to health problems, such as the risk of depression and greatly reduces quality of life.
It is therefore relevant to focus research on driving with people with NCD in order to have a reliable indicator of the person's abilities and the impact of their cognitive impairment on driving activity. The proposed study seeks to meet this need by studying the performance of people with NCD on a driving station (mini-simulator) while assessing their ability to evaluate their performance.
To achieve this goal, people with NCDs will perform tasks on a driving simulator. In addition, after each task on the driving simulator, they will answer questions about how they evaluate their own driving. Two assessors will observe the participants' driving and will estimate their driving performance. By comparing the driver's self-assessment with the assessors' assessment, an "awareness score of driving ability" will be calculated to determine whether the driver correctly assessed his or her performance.
Another project already underway aims to collect similar data from people without a diagnosis of NCDs (control group).
The principal objective of the present study is to compare the driving performance in a simulator and the awareness of driving ability of people with NCDs with those of a control group. Secondary objectives are :
1. to measure driving performance in a simulator and awareness of driving abilities (i.e. self-assessment skills) of people with NCDs.
2. to analyse driving performance and awareness of driving abilities according to the diagnosis and severity of the disorder (i.e. minor or major neurocognitive disorders).
3. to establish a methodology to identify a driver at risk of dangerous driving.
It is mainly an exploratory study however some hypotheses can be made :
* The driving performance and awareness of driving skills of people with NCDs are poorer compared to those of older, control individuals.
* Individuals' driving performance and awareness of driving ability are lower in the presence of major NCDs compared to minor NCDs.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE
NCT04493957
Vehicle Automation Impact on Drivers
NCT03893006
Interest of Two Digital Devices for the Diagnosis of Neurocognitive Disorders in Elderly People With Cognitive Symptoms.
NCT06032611
Screening of Psycho-cognitive Troubles in Elderly Patients
NCT00831805
Identification of Neurocognitive Disorders by General Practitioners in Primary Care
NCT03678376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal or corrected vision
* B licence holder with 3+ years driving experience
* Active drivers or drivers who stopped driving less than 2 months ago (time between the medical consultation and the day in the day care hospital)
* For participants able to give consent:
* Written informed consent to participate in the study
* Informed consent of the participant in the presence of his/her curator.
* For participants who are not able to receive information and to give consent:
* Written informed consent of the legal representative (tutor) for participants under tutelage.
* Signature of a relative (family member and/or trusted person) of the participant
* The participant has to be affiliated to a social security scheme.
Exclusion Criteria
* People with vestibular disorders, motion sickness or migraines
* Psychiatric history (e.g. schizophrenia)
* Non-stabilized use of antidepressants and/or anxiolytics (started or modified within the last 3 months)
* History of alcoholism
* Use of anti-epileptics
* Osteo-articular pathologies compromising walking
50 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
University Gustave Eiffel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital des Charpennes
Villeurbanne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Delphin-Combe F, Coste MH, Bachelet R, Llorens M, Gentil C, Giroux M, Paire-Ficout L, Ranchet M, Krolak-Salmon P. An innovative therapeutic educational program to support older drivers with cognitive disorders: Description of a randomized controlled trial study protocol. Front Neurol. 2022 Jul 18;13:901100. doi: 10.3389/fneur.2022.901100. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UGustaveEiffel
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.